Τόμος 13 (1999) – Τεύχος 1 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 13 (1999) – Issue 1 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Pharmacology Department, Medical School, Athens University, Athens, Greece

2. Ophthalmology Department, NIMTS Military Hospital, Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.  Sutherland E.W., Robinson G.A., Butcher R.W.: Circulation 37: 279 (1968)

3.  Lipkin D., Cook W.H., Markham R.: Adenosine 3′-5′ phosphoric acid: a proof structure. J. Amer. Chem. Soc. 81: 6198 (1959)

4.  Montminy M.R., Bilezikgian L.M.: Binding of nuclear protein to the c-AMP response element of the somatostatin gene. Nature 328: 175 (1987)

5.  Jost J.P., Richenberg H.V.: Cyclic AMP. Annu. Rev. Biochem.: 741 (1971)

6.  Waitzmann M., Woods, D.: Some characteristics of an adenylcyclase preparation from rabbit ciliary process tissue). Exp. Eye Res. 12: 99 (1971)

7.   Neufeld A.H., Jambol L.M., Sears, M.L.: Cyclic-AMP in the aqueous humor. The effects of adrenergic agents. Exp. Eye. Res. ID. 242 (1972)

8.  Neufeld A., Sears M.: Cyclic-AMP in ocular tissues of the rabbit, monkey and human, invest. Ophth. 13: 475 (1974)

9.  Chalfie M., Neufeld A., Zadunaisky J Action of epi-nephrine and her cyclic AMP-mediated agent on the chloride transport of the frog cornea. Invest. Ophth. 111B: 644 (1972)

10.            Neufeld A., Sears M.: Adenosine 3′-5′ monophosphate analogue increase the outflow facility of the primate eye. Invest. Ophth. 149: 688 (1975)

11. Moroi S.E., Lichter P.R.: Ocular Pharmacology. In: Goodman and Gilman’s. The Pharmacological Basis of Therapeutics, 9^th Ed. (1996)

12.            Neufeld A.H., Chavis R., Sears M.: Cyclic-AMP in the aqueous humor: the effects of repeated topical epinephrine administration and sympathetic denervation. Exp. Eye Res. 16: 265 (1973)

13.            Dueker K., Tozgeier Vegge, Sears M.: Adenosine 3′-5′ monophosphate increases the outflow of aqueous humor from the rabbit eye. Invest. Ophth. 141: 40 (1975)

14.            Trichopoulos D.: Essentials of Medical Statistics. Pp. 44-46, Parisianos Publ., Athens, Greece, 1971

15.            Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th Ed., p. 65,1633, Intern., Ed., 65: 1633

16.            Petounis A.: Pharmacological investigation of prostaglandins effect on the intraocular pressure and pupil’s diameter of rabbits. Doctoral thesis, Athens, 1976

17. Hoffman, B. Brian: Adrenoceptor-blocking Drugs. In: Basic and Clinical Pharmacology (B.G. Katzung, ed.), pp. 87,148-149, 6th Edition, Langel (1995)

18.            Elena P.P., Kosinia-Boix M., Denis P., et al.: Alpha2-adrenergic receptors in rat and rabbit eye. A tritium sensitive film autoradiography. Ophthalmic Res. 21: 309-314 (1989)

19.            Wax M.B., Molinoff P.B.: Distribution and properties of beta adrenergic receptors in human iris-ciliary body. Invest. Opthalmol. Vis. Set. 28: 420-430 (1987)

20.            Gharagogloonz, Bruhaker R.F.: Effect of apraclonidine in long term timolol users. Ophthalmol. 98: 1543-1546 (1991)

21.            Robinson J ,C., Kaufman P.I.: Effects and interactions of epinephrine, norepinephrine, timolol and betaxolol on outflow quality in the cynomologus monkey. Am. J. Ophthalmol. 95: 189-94 (1990)

22.            Weisz A., Bresciani F.: Estrogen induces expression of c-fos and c-myc proto-oncogenes in rat uterus. Mol. Endocrinol. 2: 816-824 (1988)

23.            Chiappetta C., Kirkland J.C., Loose-Mitchell D.S., Murthy L., Stancel G.M.: Estrogen regulates expression of the jun family of proto-oncogenes in the uterus. J. Steroid Biochem. Mol. Biol. 41: 113-123 (1992)

24.            Weisz A., Rosales R.: Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 18: 5097-5106 (1990)

25.            Hyder S.M., Nawaz Z., Chiappetta C., Yokoyama K., Stancel G.M.: The protoncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J. Biol. Chem. 270: 8506-8513 (1995)

26.            Zachos G., Zoumpourlis V., Sekeris C.E., Spandidos, D.A.: Binding of the glucocorticoid and estrogen receptor to the human H-ras oncogene sequences, int. J. Oncol. 6: 595-600 (1995)

27.            Kirkland J.L., Murthy L., Stancel G.M.: Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology 130: 3223-3230 (1992)

28.            Beato M.: Gene regulation by steroid hormones. Cell 56: 335-344 (1989)

29.            Sekeris C.E.: Hormonal steroids act as tumor promoters by modulating oncogene expression. J. Cancer Res. Clin. Oncol. 117: 96-101 (1991)

30.            Schuchard M., Landers J.P., Punkay-Sandhu N., Spelsberg T.C.: Steroid hormone regulation of nuclear proto-oncogenes. Endocr. Rev. 14: 659-669 (1993)

31.            Bamberger A.M., Bamberger C.M., Gellersen B., Schulte H.M.: Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc. Natl. Acad. Sci. USA 93: 6169-6174 (1996)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr